You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dactinomycin

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

Recruiting
  • Sarcoma
  • +3 more
  • Isolated Limb Infusion
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 21, 2022

Toxicodynamics of Daptomycin in Bone and Joint Infections

Recruiting
  • Dactinomycin Adverse Reaction
  • Bone and Joint Infection
  • patients having had BJI or PJI treated with daptomycin
  • Lyon, France
    Hospices Civils de Lyon
May 5, 2022

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

GTD, Gestational Trophoblastic Neoplasia, Stage I GTD Trial in Beijing (Methotrexate, Leucovorin, Dactinomycin)

Recruiting
  • Gestational Trophoblastic Tumor
  • +6 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 14, 2021

Pleuropulmonary Blastoma Trial in Minneapolis (Vincristine, Dactinomycin, Cyclophosphamide)

Active, not recruiting
  • Pleuropulmonary Blastoma
  • Minneapolis, Minnesota
    Anne K Harris
May 26, 2021

Description of Eosinophilic Pneumonia in BJI/PJI Treated by

Recruiting
  • Dactinomycin Adverse Reaction
  • Bone and Joint Infection
  • Description of eosinophilic pneumonia due to daptomycine
  • Lyon, France
    Hospices Civils de Lyon
Nov 6, 2020

Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)

Active, not recruiting
  • Ewing's Sarcoma
  • Standard treatment (as per protocol ISG SSG III)
  • Intensified chemotherapy
  • Aviano, Pordenone, Italy
  • +13 more
Oct 29, 2021

Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

Recruiting
  • Embryonal Rhabdomyosarcoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Aug 17, 2022

Choriocarcinoma, FIGO Stage I GTD, FIGO Stage II GTD Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Choriocarcinoma
  • +4 more
  • Dactinomycin
  • +3 more
  • Anchorage, Alaska
  • +288 more
Aug 10, 2022

Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor Trial in Worldwide (procedure, drug, biological, radiation)

Active, not recruiting
Has Results
  • Stage I Wilms Tumor
  • +2 more
  • therapeutic conventional surgery
  • +4 more
  • Birmingham, Alabama
  • +220 more
Jan 4, 2022

Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,

Suspended
  • Alveolar Rhabdomyosarcoma
  • +5 more
  • Birmingham, Alabama
  • +386 more
Aug 18, 2022

Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide

Completed
Has Results
  • Adult Rhabdomyosarcoma
  • +3 more
  • conventional surgery
  • +4 more
  • Birmingham, Alabama
  • +162 more
Nov 17, 2021

Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma Trial in Worldwide (drug, biological,

Active, not recruiting
Has Results
  • Adult Malignant Mesenchymoma
  • +10 more
  • Irinotecan Hydrochloride
  • +6 more
  • Birmingham, Alabama
  • +211 more
Dec 9, 2021

Rhabdomyosarcoma Trial in Sutton, Manchester (Irinotecan, Actinomycin D, Doxorubicin)

Recruiting
  • Rhabdomyosarcoma
  • Camperdown, Australia
  • +89 more
Jan 3, 2023

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

Recruiting
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • DOC Group B
  • +16 more
  • Valhalla, New York
    New York Medical College
Jun 9, 2022

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 1, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 7, 2023

Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, Childhood Kidney Wilms Tumor Trial in Worldwide (biological, drug,

Active, not recruiting
Has Results
  • Adult Kidney Wilms Tumor
  • +10 more
  • Dactinomycin
  • +4 more
  • Birmingham, Alabama
  • +168 more
Mar 23, 2022

Brain Cancer, Choroid Plexus Tumors Trial in Worldwide (Carboplatin, Cisplatin, Cyclophosphamide)

Terminated
Has Results
  • Brain Cancer
  • Choroid Plexus Tumors
  • Boston, Massachusetts
  • +4 more
Aug 1, 2019

Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)

Recruiting
  • Gestational Trophoblastic Neoplasms
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Jun 2, 2022

0.5-14 Year Old Children With Nephroblastoma Trial in Shenyang (Vincristine, Oxytetracycline/ Cyclophosphamide, Liposomal

Not yet recruiting
  • 0.5-14 Year Old Children With Nephroblastoma
  • Shenyang, Liaoning, China
    Shenjing Hospital
Mar 25, 2019

Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q, Stage IV Wilms Tumor Trial in Worldwide (drug,

Active, not recruiting
Has Results
  • Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
  • Stage IV Wilms Tumor
  • doxorubicin hydrochloride
  • +6 more
  • Birmingham, Alabama
  • +206 more
Mar 23, 2022

Kidney Cancer Trial in Worldwide (biological, drug, procedure, radiation)

Completed
  • Kidney Cancer
  • dactinomycin
  • +7 more
  • Birmingham, Alabama
  • +234 more
Feb 23, 2021

Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, GTD Trial in Wuhan, Jinan, Hangzhou (MTX 1, MTX 2,

Unknown status
  • Gestational Trophoblastic Disease
  • +3 more
  • MTX 1
  • +2 more
  • Wuhan, Hubei, China
  • +2 more
Dec 23, 2019

Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

Recruiting
  • Bone Sarcoma
  • +6 more
  • Treatment by Regorafenib
  • Treatment by Placebo
  • Besançon, France
  • +15 more
Aug 18, 2022